HUGroup Holdings (4544) AI Stock Analysis

• Market Cap: $181.36B
• Dividend Yield: 3.92%
• Average Volume (3M): 220.18K
• Price to Earnings (P/E): 66.2
• Beta (1Y): 0.46
• Revenue Growth: 2.56%
• EPS Growth: N/A
• Country: JP
• Employees: 5,295
• Sector: Healthcare
• Sector Strength: 44
• Industry: Medical - Diagnostics & Research
• EPS (TTM): -0.58
• Shares Outstanding: 57,473,824
• 10 Day Avg. Volume: 177,310
• 30 Day Avg. Volume: 220,176
• PEG Ratio: 0.23
• Price to Book (P/B): 1.32
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 10.17
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $2,777.37
• Price Target Upside: -13.61% Downside
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 3

• Rating: 63 Neutral
• Price Target: ¥3,255.00 ▲(1.24%Upside)

HUGroup Holdings shows a balanced performance with a strong technical momentum and robust dividend yield, offset by a high P/E ratio and past cash flow volatility. The primary strengths are operational improvements and technical indicators, while high valuation and leverage risks are key considerations.

HUGroup Holdings Business Overview & Revenue Model

Company Description

H.U. Group Holdings, Inc., through its subsidiaries, provides laboratory testing products and services in Japan. The company offers lab testing and its related services to medical institutions; self-medication services; food, environment, and cosmetic testing services; and testing services through corporate health insurance associations. It also researches, develops, manufactures, and sells in vitro diagnostic devices, which includes the LUMIPULSE, an automatic chemiluminescent enzyme immunoassay system that offers reagents for infectious disease, cancer, and lifestyle disease to medical institutions and testing centers; and ESPRINE, a rapid diagnostics kit series for influenza, hepatitis B, and the novel coronavirus, as well as supplies ingredients for test drugs. In addition, the company provides support services related to hospital administration work, including aid for surgical procedures and endoscope room work, inspection and maintenance services for medical equipment, and in-hospital logistics management and transportation services; and rents and sells nursing-care equipment and supplies. Further, it offers home-visit nursing care services. The company was formerly known as Miraca Holdings Inc. and changed its name to H.U. Group Holdings, Inc. in July 2020. H.U. Group Holdings, Inc. was incorporated in 1950 and is headquartered in Tokyo, Japan.

How the Company Makes Money

HUGroup Holdings generates revenue through several key streams. The company earns money by selling medical devices and diagnostic equipment to healthcare facilities and laboratories. Another significant revenue stream comes from providing laboratory testing services, which includes various clinical tests and diagnostic analyses for medical institutions. Additionally, HUGroup Holdings may engage in partnerships or collaborations with other healthcare organizations to expand its service offerings and increase market reach, contributing to its overall earnings. The company leverages its expertise in medical technology and diagnostics to maintain a competitive edge in the healthcare market.

HUGroup Holdings Financial Statement Overview

Summary

HUGroup Holdings is in a recovery phase with improving operating margins and a strong equity base. Revenue growth is modest, but EBIT and EBITDA margin recovery indicates operational improvements. Rising debt levels pose a potential risk, and cash flow management, despite improvements, remains a concern due to past volatility.

Income Statement

HUGroup Holdings has shown fluctuating revenue trends with a recent annual growth rate of 2.56%. Gross profit margins have been relatively stable, averaging around 27% over the years, but there was a significant dip in net income during 2024. The company has managed to recover its EBIT and EBITDA margins in 2025, indicating some operational recovery.

Balance Sheet

The company's balance sheet reflects strong equity, with a moderate debt-to-equity ratio of 0.63 in 2025. There is a consistent high equity ratio averaging around 48%, indicating a strong capital base. However, the increase in total debt over the years suggests a potential leverage risk.

Cash Flow

HUGroup Holdings has seen volatility in its free cash flow, with a significant recovery in 2025 after a negative free cash flow in 2024. The operating cash flow to net income ratio is robust, indicating efficient cash generation relative to net income. However, the fluctuations in free cash flow highlight potential cash management challenges.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	243.03B	236.95B	260.91B	272.94B	223.02B
Gross Profit	66.72B	63.23B	89.92B	111.80B	76.21B
EBITDA	24.55B	13.65B	43.08B	65.12B	37.89B
Net Income	2.76B	-7.55B	15.68B	29.60B	17.47B
Balance Sheet
Total Assets	279.58B	290.85B	297.92B	286.59B	252.75B
Cash, Cash Equivalents and Short-Term Investments	40.88B	39.95B	44.41B	46.71B	43.76B
Total Debt	86.65B	81.94B	77.16B	73.00B	80.45B
Total Liabilities	142.28B	148.34B	147.88B	146.41B	137.45B
Stockholders Equity	137.29B	142.50B	150.04B	140.18B	115.31B
Cash Flow
Free Cash Flow	17.88B	-1.01B	10.85B	20.10B	14.40B
Operating Cash Flow	21.96B	16.55B	32.53B	55.23B	35.59B
Investing Cash Flow	-15.96B	-16.05B	-29.58B	-30.86B	-28.27B
Financing Cash Flow	-5.30B	-5.78B	-5.76B	-21.73B	-1.57B

HUGroup Holdings Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3215.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4544, the sentiment is Positive. The current price of 3215 is above the 20-day moving average (MA) of 3188.05, above the 50-day MA of 3102.59, and above the 200-day MA of 2703.80, indicating a bullish trend. The MACD of 28.34 indicates Positive momentum. The RSI at 57.68 is Neutral, neither overbought nor oversold. The STOCH value of 61.49 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4544.

HUGroup Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4544	63 Neutral	$181.36B	66.16	1.93%	3.92%	2.56%	―
Sector *	52 Neutral	$7.47B	-0.04	-63.86%	2.34%	16.17%	0.25%
BMZ	―	€763.21M	19.77	4.86%	2.95%	―	―
4886	76 Outperform	¥64.00B	13.45		2.08%	2.06%	-32.48%
9776	74 Outperform	¥3.50B	6.97		2.24%	2.28%	30.17%
4671	67 Neutral	¥22.97B	12.65		5.48%	0.71%	19.35%
4549	66 Neutral	¥68.28B	32.95		2.57%	1.22%	-9.27%

HUGroup Holdings Corporate Events

H.U. Group Holdings Reports No Treasury Stock Acquisition in June

H.U. Group Holdings announced that it has not acquired any of its treasury stock during the specified period from June 1, 2025, to June 30, 2025, despite a prior resolution to acquire up to 2,500,000 shares. The acquisition was intended to be conducted through market purchases on the Tokyo Stock Exchange, but no shares were acquired, impacting the company’s stock repurchase strategy.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Holdings Reports Zero Treasury Stock Acquisition

H.U. Group Holdings announced that it has not acquired any treasury stock as of May 30, 2025, despite a resolution to purchase up to 2.5 million shares by March 31, 2026. This lack of acquisition may impact the company’s market strategy and shareholder value, as the planned repurchase was intended to enhance stock value and optimize capital structure.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Holdings Announces Consistent Dividend Payout

H.U. Group Holdings, Inc. has announced a resolution to pay dividends of surplus with a record date of March 31, 2025, maintaining a dividend of 63 yen per share, consistent with the previous fiscal year. This decision underscores the company’s commitment to returning profits to shareholders, aligning with its policy of maintaining stable and consistent dividends.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Holdings Announces Strategic Share Repurchase Plan

H.U. Group Holdings, Inc. has announced a strategic move to repurchase its own shares, as part of its new five-year medium-term management plan termed the ‘Investment Harvesting Phase.’ The company aims to enhance shareholder returns with a targeted Dividend on Equity ratio of 6%, and views share repurchases as strategic investments, planning to acquire 2,500,000 common shares through market purchases on the Tokyo Stock Exchange by March 2026.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Holdings Reports Financial Turnaround and Positive Outlook

H.U. Group Holdings reported a notable turnaround in its financial performance for the fiscal year ended March 31, 2025, with net sales increasing by 2.6% to ¥243,025 million and a return to profitability with a profit attributable to owners of the parent at ¥2,761 million. This marks a significant recovery from the previous fiscal year’s losses, indicating improved operational efficiency and market conditions. The company also forecasts continued growth in the fiscal year ending March 31, 2026, with expected increases in net sales and profits, reflecting a positive outlook for stakeholders.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Holdings Revises Earnings Forecast for Fiscal Year 2025

H.U. Group Holdings has revised its full-year consolidated earnings forecast for the fiscal year ending March 31, 2025, due to underperformance in its LTS and IVD businesses. The company expects operating profit to be significantly lower than previously forecasted, influenced by foreign exchange impacts and changes in profit categorization, though the year-end dividend forecast remains unchanged.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.